Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1991 Oct;46(10):737–738. doi: 10.1136/thx.46.10.737

Mycobacterium fortuitum lung abscess treated with ciprofloxacin.

J Vadakekalam 1, M J Ward 1
PMCID: PMC463397  PMID: 1750023

Abstract

Mycobacterium fortuitum rarely causes lung disease. Although treatment in the past has included intravenous antibiotics, this is the first report of a Mycobacterium fortuitum lung abscess that resolved with a prolonged course of oral ciprofloxacin alone. There is no evidence of recurrence 14 months after the end of treatment.

Full text

PDF
737

Images in this article

737Image
on p.737
738Image
on p.738

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Hand W. L., Sanford J. P. Mycobacterium fortuitum--a human pathogen. Ann Intern Med. 1970 Dec;73(6):971–977. doi: 10.7326/0003-4819-73-6-971. [DOI] [PubMed] [Google Scholar]
  2. Poon P. Y. MR imaging of the thorax. Chest. 1987 Jul;92(1):1–2. doi: 10.1378/chest.92.1.1. [DOI] [PubMed] [Google Scholar]
  3. Swenson J. M., Wallace R. J., Jr, Silcox V. A., Thornsberry C. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrob Agents Chemother. 1985 Dec;28(6):807–811. doi: 10.1128/aac.28.6.807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Wallace R. J., Jr, Swenson J. M., Silcox V. A., Bullen M. G. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. J Infect Dis. 1985 Sep;152(3):500–514. doi: 10.1093/infdis/152.3.500. [DOI] [PubMed] [Google Scholar]
  5. Wallace R. J., Jr, Swenson J. M., Silcox V. A., Good R. C., Tschen J. A., Stone M. S. Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis. 1983 Jul-Aug;5(4):657–679. doi: 10.1093/clinids/5.4.657. [DOI] [PubMed] [Google Scholar]
  6. Wolinsky E. Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis. 1979 Jan;119(1):107–159. doi: 10.1164/arrd.1979.119.1.107. [DOI] [PubMed] [Google Scholar]
  7. Woods G. L., Hall G. S., Schreiber M. J. Mycobacterium fortuitum peritonitis associated with continuous ambulatory peritoneal dialysis. J Clin Microbiol. 1986 Apr;23(4):786–788. doi: 10.1128/jcm.23.4.786-788.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Woods G. L., Washington J. A., 2nd Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects. Rev Infect Dis. 1987 Mar-Apr;9(2):275–294. doi: 10.1093/clinids/9.2.275. [DOI] [PubMed] [Google Scholar]
  9. Young L. S., Berlin O. G., Inderlied C. B. Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria. Am J Med. 1987 Apr 27;82(4A):23–26. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES